Joyvié Health raises €897K pre-seed to rethink continence underwear

What's the deal? UK-based Joyvié HealthDealroom has a profile for this one. Try Dealroom → has closed a pre-seed funding round of €897K ($1.04M) to develop continence underwear designed from first principles. The product aims to reduce stool-to-skin contact, maintain skin integrity, and ease the burden on caregivers.

The round was backed by an Innovate UK grant alongside investments from HERmesa Angels, SyndicateRoomDealroom has a profile for this one. Try Dealroom →, and Lavender VenturesDealroom has a profile for this one. Try Dealroom →. The company was founded after its creator experienced personal loss related to continence care challenges.

Why now? Ageing populations across Europe and the UK are driving demand for better incontinence solutions. Existing products have seen little fundamental innovation, creating an opening for startups willing to rethink the category from scratch.

What could go wrong? Consumer health products face long timelines to build trust, especially in a market dominated by established brands with deep distribution networks. Regulatory hurdles and the challenge of scaling physical product manufacturing on a small funding base add further risk.

The signal: The backing from HERmesa Angels and Lavender Ventures reflects a growing appetite among gender-lens and impact-focused funds for overlooked care categories. With Innovate UK grant funding in the mix and Joyvié Health tagged as an early-growth company on Dealroom despite its pre-seed stage, the round suggests that investors see a credible path to scale in a market where incumbents have under-innovated for decades.

Read more: EU-Startups